Ring Therapeutics Stock

Ring Therapeutics is a multi-product platform company focused on discovering and developing Anellovector therapeutics to unlock the full potential of gene therapy. Ring is aiming to pioneer the first redosable and targetable gene therapy platform by harnessing the biology of the human commensal virome. The company seeks to expand the applications of gene therapy beyond gene replacement, with the goal of enabling a much wider array of modalities and mechanisms to treat previously inaccessible diseases.